
Resources
Airway Mycosis and the Future of Allergic Airway Disease Care
In this presentation, Dr. David B. Corry discusses his work in airway fungal diseases and how they relate to allergic airway diseases and inflammatory disorders such as inflammatory bowel disease and Alzheimer's Disease.
This Department of Medicine Grand Rounds session took place on Thursday, February 11, 2021 at 12:15 P.M.
CME Information
CME Credit Available
You may claim CME credit after watching this activity.
You will be redirected to an outside site when claiming credit and may be asked to register or log in.
Needs Statement
Faculty and trainees within the Department of Medicine who are involved in the care of patients need to be regularly updated with the recent advances and guidelines in the fields of internal medicine and quality improvement to increase clinical knowledge, and to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.
Objectives
At the conclusion of this activity, the participant should be able to:
- Demonstrate an understanding of airway mycosis pathophysiology and how it relates to common diseases such as asthma and chronic rhinosinusitis.
- Apply knowledge of airway mycosis to improving the diagnosis and management of patients with allergic airway disease.
- Extend knowledge of airway mycosis in novel directions to other poorly understood inflammatory disorders such as inflammatory bowel disease and Alzheimer's disease.
Target Audience
- Physicians
- Medical Students
- Fellows
- Residents
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Program Director
Term of Approval
February 1, 2021 through February 28, 2023. Original release date: February 1, 2021.
Disclosure Policy
The Office of Continuing Medical Education (OCME) makes every effort to develop CME activities that are scientifically based, accurate, current, and objectively presented. In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial SupportSM, Baylor College of Medicine (BCM) has implemented a mechanism requiring everyone in a position to control the content of an educational activity (e.g., directors, planning committee members, contributors, peer reviewers) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships: 1) at the time of the activity or within 12 months prior; and 2) of their spouses/partners.
Baylor College of Medicine does not view the existence of interests or relationships with commercial entities as implying bias or decreasing the value of a presentation. It is up to the participants to determine whether the interests or relationships influence the presenter with regard to exposition or conclusions.
If at any time during this activity you feel that there has been commercial or promotional bias, please inform us by using the commercial bias comments box in the evaluation form. Please answer the questions about balance in the CME activity evaluation candidly.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
David B Corry, M.D.
Professor
Baylor College of Medicine
Disclosure:
- Intellectual Property: Atropos Therapeutics, LLC
- Advisory Committee Membership: Atropos Therapeutics, LLC; DevPro Therapeutics, LLC
Program Director
Planning Committee Members
-
-
Erica Lescinskas, M.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Zaven Sargsayan, M.D.
Assistant Professor
Baylor College of Medicine and Ben Taub Hospital
Disclosure:
Nothing to disclose.
-
Chirayu Shah, M.D., M.Ed.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Stephanie Sherman, M.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Jefferson Triozzi, M.D.
Internal Medicine Resident
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Contributor
-
David B Corry, M.D.
Professor
Baylor College of Medicine
Disclosure:
- Intellectual Property: Atropos Therapeutics, LLC
- Advisory Committee Membership: Atropos Therapeutics, LLC; DevPro Therapeutics, LLC
CME Credit Available
You may claim CME credit after watching this activity.
You will be redirected to an outside site when claiming credit and may be asked to register or log in.